4Hildesheim A,Wang SS.Host and viral genetics and risk of cervical cancer:a review.Virus Res,2002,89:229-240.
5Jacobs MV,de Roda Husman AM,van den Brule AJ,et al.Group-specific differentiation between high-and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes.J Clin Microbiol,1995,33:901-905.
6Olerup O,Zetterquist H.HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours:an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.Tissue Antigens,1992,39:225-235.
7Beskow AH,Josefsson AM,Gyllensten UB.HLA class Ⅱ alleles associated with infection by HPV16 in cervical cancer in situ.Int J Cancer,2001,93:817-822.
8Madeleine MM,Brumback B,Cushing-Hauqen KL,et al.Human leukocyte antigen class Ⅱ and cervical cancer risk:a population-based study.J Infect Dis,2002,186:1565-1574.
9Sastre-Garau X,Cartier I,Jourdan-Da Silva N,et al.Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype.Obstet Gynecol,2004,104:751-755.
